Want to see HAE full AI Analyst Report?
Haemonetics (HAE) Ownership Overview
1.82% Insiders
38.40% Mutual Funds
2.58% Other Institutional Investors
28.80% ETFs
28.40% Public Companies and
Individual Investors
The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 69.78% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 28.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 12, 2025 | xxxxxxxxxxxxx | $98784 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $4479975 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $207750 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $620100 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $154572450 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,312,648 | Institution | 11.68% | 637,358,381 | |
| 4,260,442 | Institution | 9.36% | 511,125,227 | |
| 3,753,193 | Institution | 8.25% | 450,270,564 | |
| 3,719,710 | Institution | 8.18% | 446,253,609 | |
| 2,060,966 | Institution | 4.53% | 247,254,091 | |
| 1,104,349 | Institution | 2.43% | 132,488,750 | |
| 972,988 | Institution | 2.14% | 116,729,370 | |
| 865,250 | Institution | 1.90% | 103,804,043 | |
| 640,201 | Institution | 1.41% | 76,804,914 | |
| 639,350 | Institution | 1.41% | 76,702,820 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,753,193 | Institution | 8.25% | 450,270,564 | |
| 3,719,710 | Institution | 8.18% | 446,253,609 | |
| 972,988 | Institution | 2.14% | 116,729,370 | |
| 865,250 | Institution | 1.90% | 103,804,043 | |
| 640,201 | Institution | 1.41% | 76,804,914 | |
| 639,350 | Institution | 1.41% | 76,702,820 | |
| 612,960 | Institution | 1.35% | 73,536,811 | |
| 506,987 | Institution | 1.11% | 60,823,230 | |
| 363,531 | Institution | 0.80% | 43,612,814 | |
| 345,956 | Institution | 0.76% | 41,504,341 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,631,434 | Institution | 3.59% | 195,723,137 | |
| 1,567,099 | Institution | 3.44% | 121,152,424 | |
| 1,449,410 | Institution | 3.19% | 152,622,873 | |
| 1,159,336 | Institution | 2.55% | 139,085,540 | |
| 1,024,561 | Institution | 2.25% | 107,886,273 | |
| 512,433 | Institution | 1.13% | 53,959,195 | |
| 406,310 | Institution | 0.89% | 48,745,011 | |
| 352,920 | Institution | 0.78% | 36,943,666 | |
| 342,386 | Institution | 0.75% | 41,076,048 | |
| 333,278 | Institution | 0.73% | 35,094,173 |
FAQ
Who Owns Haemonetics Corp. (HAE)?
According to the latest TipRanks data, approximately 2.58% of the company's stock is held by institutional investors, 1.82% is held by insiders, and 28.40% is held by retail investors.
What percentage of Haemonetics Corp. (HAE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.58% of Haemonetics Corp. (HAE) stock is held by institutional investors.
What percentage of Haemonetics Corp. (HAE) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.40% of Haemonetics Corp. (HAE) stock is held by retail investors.
Who owns the most shares of Haemonetics Corp. (HAE)?
iShares owns the most shares of Haemonetics Corp. (HAE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.